11:32 am NovaBay Pharma: WoundSource reports on the role of NovaBay’s NeutroPhase in treatment of ‘flesh-eating’ infections; ‘NeutroPhase has been shown in the laboratory to neutralize the toxins that make these infections so deadly’
View todays social media effects on NBY
View the latest stocks trending across Twitter. Click to view dashboard
See who NovaBay is hiring next, click here to view
